Catalent Pharma Solutions
Presence
Catalent Pharma Solutions is one of the...
Catalent Pharma Solutions is a company listed under the stock ticker CTLT (US).
Catalent Pharma Solutions has a direct presence in 2 countries.Catalent Pharma Solutions has 3 subsidiaries including Catalent Biologics, Catalent Cell & Gene Therapy and Catalent Pharma Germany.
They are in:
Acquisition, funding and merger involving Catalent Pharma Solutions.
- Novo Holdings has announced the acquisition of Catalent Pharma Solutions (posted on February 8 2024).
- Catalent Pharma Solutions has acquired Metrics Contract Services (posted on August 12 2022).
Executives
View the org chart displaying its 57 main executives
Most searched biographies at Catalent Pharma Solutions
- Alessandro Maselli, President and Chief Executive Officer
- Jack Stahl, Board Member and Lead Director
- Michael Barber, Board Member
Popular executive movements at Catalent Pharma Solutions
- John Greisch, who was Director, is promoted to Executive Chairman of the Board (posted on August 30 2023).
- Frank D'Amelio has joined the company as Director (posted on August 30 2023).
- Steven Barg has joined the company as Director (posted on August 30 2023).
Click here to view some more movements at Catalent Pharma Solutions
Create your alert
to follow the executive moves at Catalent Pharma Solutions.
Medical Equipment
Catalent Pharma Solutions has 986 competitors including Philips (Netherlands), Medtronic (Ireland) and Thermo Fisher Scientific (United States (USA)).
Popular M&A news in Medical Equipment
- Medigus will change its company name to Xylo Technologies on Apr 12, 2024. (posted on April 12 2024).
- Johnson & Johnson has announced the acquisition of Shockwave Medical (posted on April 6 2024).
- Carlsmed has just announced a $52 Million fundraising (posted on March 22 2024).
Popular contacts in Medical Equipment
News
Press releases by Catalent Pharma Solutions
- Catalent Publishes Fifth Annual Corporate Responsibility Report
- Catalent Adds Potent Capsule Filling Capabilities for Inhaled Dry Powders at its Boston Facility
- Novo Holdings to Acquire Catalent | Catalent Pharma Solutions
- Catalent Commits to Reducing Greenhouse Gas Emissions by 2030
- Catalent Appoints David McErlane as Biologics Segment Leader
- Catalent Appoints Lisa Evoli Senior Vice President and Chief Human Resource Officer
- Catalent Appoints New Senior Vice President & Chief Financial Officer
- Catalent and JLABS Symposium to Discuss Accelerated Development and Manufacturing of Biologics
- Catalent Expands OneBio® Suite for Integrated Development, Manufacturing and Supply Across Biologic Modalities
- Catalent Adds New Cryogenic Capabilities at Shiga, Japan, Facility to Support Clinical Supply Demand for Cell and Gene Therapy Development
- View more press releases Close
Social media about Catalent Pharma Solutions
- Catalent Pharma Solutions on Wikipedia, Google News & Yahoo Finance
- Catalent Pharma Solutions on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Alessandro Maselli 
Call Catalent Pharma Solutions at +1 732...
